期刊文献+

^(99m)Tc-DTPA肾动态显像评价水化治疗预防对比剂致肾功能损伤的效果 被引量:4

Preventive effect of hydration therapy reviewed by ^(99m)Tc-DTPA renal dynamic imaging on contrast induced nephropathy
暂未订购
导出
摘要 目的探讨99mTc-DTPA肾动态显像评价水化治疗预防对比剂致肾功能损伤的价值。方法选择17例接受冠状动脉造影(CAG)检查的肾功能不全代偿期患者,入选患者术前12 h开始水化治疗,按照1~1.5 ml/(kg.h)输入生理盐水和5%NaHCO3注射液(125 ml),术后继续维持生理盐水输入12 h。CAG前24h、后72 h分别行99mTc-DTPA肾动态显像,测定肾小球滤过率(GFR),同时测定血清尿素氮(BUN)、血清肌酐(Scr)进行对比分析。结果 17例患者术后双肾GFR、血BUN、Scr水平,与造影前比较,差异均无统计学意义(P均>0.05)。结论99mTc-DTPA肾动态显像进一步证实了水化治疗预防对比剂导致肾功能损伤的有效性。 Objective To investigate the value of hydration therapy reviewed by 99mTc-DTPA renal dynamic imaging in preventing contrast induced nephropathy.Methods The patients of compensatory stage of renal insufficiency(n=17) accepted coronary angiography(CAG) were selected and given hydration therapy 12 hours before CAG.They were infused normal saline solution[1~1.5 ml/(kg·h)]and 5% sodium bicarbonate injection(125 mL) before CAG,and the infusion of normal saline solution was maintained for 12 hours after CAG.All patients were given 99mTc-DTPA renal dynamic imaging 24 hours before CAG and 72 hours after CAG.The glomerular filtration rate(GFR),blood urea nitrogen(BUN) and serum creatinine(Scr) were detected,compared and analyzed.Results The changes of GFR,BUN and Scr were not statistically different in 17 patients before and after CAG(all P0.05).Conclusion 99mTc-DTPA renal dynamic imaging can confirm further the effect of hydration therapy in prevention and treatment of impaired renal function induced by contrast agent.
出处 《中国循证心血管医学杂志》 2012年第1期23-24,28,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 水化治疗 放射性核素显像 冠状动脉造影 对比剂肾病 Hydration therapy Radionuclide imaging Coronary angiography Contrast induced nephropathy
  • 相关文献

参考文献9

二级参考文献76

  • 1高力丁,李兴.血半胱氨酸蛋白酶抑制剂C诊断肾功能损害的研究进展[J].医学综述,2004,10(11):693-695. 被引量:23
  • 2杜晓英,李林法,何强,吴东波,陈江华.^(99m)Tc-DTPA肾动态显像检测肾小球滤过率的临床应用评价[J].中华肾脏病杂志,2006,22(5):266-270. 被引量:53
  • 3Mehran R. Contrast - induced nephropathy remains a serious complication of PCI. J Interv Gardiol, 2007,20 (3) : 236 - 240.
  • 4Orner T. Risk Markers for Contrast - Induced Nephropathy. American Journal of the Medical Sciences, 2007,334 (4) : 283-290.
  • 5Ultramari FT, Bueno Rda R, da Cunha CL, et al. Contrast media - induced nephropathy following diagnostic and therapeutic cardiac catheterization. Arq Bras Cardiol, 2006,87 (3) : 378 - 390.
  • 6Nash K, Hafeez A, Hou S. Hospital - acquired renal insufficiency. Am J Kidney Dis,2002,39(5) :930 - 936.
  • 7Bartorelli AL, Marenzi G. Contrast - Induced Nephropathy. Journal of Interventional Cardiology, 2008,21 ( 1 ) : 74 - 85.
  • 8McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med, 1997,103 (5) : 368 - 375.
  • 9Levy EM, Viseoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA, 1996,275 (19) :1489 -1494.
  • 10Kowalczyk J, Lenarczyk R, Kowalski O, et al. Different types of Renal Dysfunction in Patient with AMI Treated with PCI. J Interv Cardiol, 2007,20(2) :143 - 152.

共引文献81

同被引文献23

  • 1Hoste EA,De Waele JJ,Gevaert SA,et al. Sodium bicarbonate forprevention of contrast-induced acute kidney injury : a systematicreview and meta-analysis [J]. Nephrol Dial Transplant,2010,25(3):747-758.
  • 2Castini D, Lucreziotti S, Bosotti L, et al. Prevention of contrast-in- duced nephropathy: a single center randomized study [J] . Clin Cardi- al, 2010, 33 (3) : E63-E68.
  • 3Melfi R, Nusca A, Patti G, et al. Statins and their rale in pre-percuta- neous coronary intervention [J] . Curr Cardial Rep, 2010, 12 (4) : 295-301.
  • 4Mautone A, Brown JR. Contrast-induced nephropathy in patients un- dergoing elective and urgent procedures [J] . J Interv Cardial, 2010, 23 (1) :78-85.
  • 5James MT, Ghali WA, Knudtson ML, et al. Associations between acute kidney injury and cardiovascular and renal outcomes after coronary an- giography [J] . Circulation, 2011, 123 (4) : 409-416.
  • 6Ozhan H, Erden I, Ordu S, et al. Efficacy of short-term high-dose ator- vastatin for prevention of contrast-induced nephropathy in patients un- dergoing coronary angiography [J] . Angialogy, 2010, 61 (7) : 711-714.
  • 7李为民,薛竞宜.对比剂肾病的研究进展[J].中国循环杂志,2010,25(5):325-326. 被引量:38
  • 8马兴杰,董岸莺,韩国华.造影剂肾病的研究进展[J].重庆医学,2011,40(13):1326-1329. 被引量:27
  • 9张任重,崔天蕾,付平.对比剂肾病的危险因素及其预防[J].中国中西医结合肾病杂志,2011,12(5):451-453. 被引量:3
  • 10王迪生,李霞,孔刘莎.阿托伐他汀与N-乙酰半胱氨酸对对比剂肾病大鼠肾功能保护作用的研究[J].中国实用医药,2011,6(25):249-250. 被引量:1

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部